Literature DB >> 12523583

Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type.

M Younes1, D E Henson, A Ertan, C C Miller.   

Abstract

BACKGROUND: The incidence of esophageal adenocarcinoma in White males has been reported to be increasing. The aims of this study were to determine: 1) the incidence trends of esophageal carcinoma in the United States with an emphasis on histologic type, sex, and ethnicity, 2) whether the reported increase in stage IV tumors can be confirmed, and 3) survival trends and factors affecting survival.
METHODS: Data from the SEER program of the National Cancer Institute with submission dates 1973-98 were used. Data on Hispanics were available for analysis only for the years 1992-98. Statistical analysis was performed utilizing SEER*Stat and SAS statistical software packages.
RESULTS: The incidence of adenocarcinoma in White males is still rising (7.8%/year, P < 0.0001); however, the same trend was observed for White females (6.48%/year; P < 0.0001). Hispanic males (3.91 %/year; P < 0.02), and Hispanic females (9.4%/ year; P < 0.04). The incidence of squamous cell carcinoma has been steadily declining in White males and females and in Black females since 1973, with the incidence showing a dramatic and significant decline in Black males beginning in 1992 (8.53%/year; P = 0.0009). Stage 4 carcinoma is declining in incidence. Survival of patients with esophageal carcinomas has been improving. In a Cox multivariate model, independent prognostic factors in esophageal carcinoma included tumor stage, tumor type, gender, race, age at diagnosis, and year of diagnosis.
CONCLUSIONS: 1) The incidence of adenocarcinoma continues to rise in White males and females, but also in Hispanics, while squamous cell carcinoma is declining; 2) the incidence of stage 4 carcinomas has been declining, and 3) survival has been steadily improving, independently of all other risk factors.

Entities:  

Mesh:

Year:  2002        PMID: 12523583     DOI: 10.1080/003655202762671215

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  39 in total

1.  Sensitivity of upper endoscopy in diagnosing esophageal cancer.

Authors:  Richard S Bloomfeld; David I Bridgers; Benoit C Pineau
Journal:  Dysphagia       Date:  2005       Impact factor: 3.438

2.  Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy.

Authors:  Javier Valencia Julve; Vicente Alonso Orduña; Ricardo Escó Barón; Miriam López-Mata; Agustina Méndez Villamón
Journal:  Clin Transl Oncol       Date:  2006-01       Impact factor: 3.405

3.  Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus.

Authors:  Tong Chen; Fei Yan; Jiaming Qian; Mingzhou Guo; Hongbing Zhang; Xiaofei Tang; Fang Chen; Gary D Stoner; Xiaomin Wang
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-01

4.  Endoscopic mucosal resection in the setting of Barrett's esophagus.

Authors:  Jason K Lee; Robert Enns
Journal:  Can J Gastroenterol       Date:  2007-03       Impact factor: 3.522

5.  Descriptive epidemiology of esophageal carcinoma in the Ohio Cancer Registry.

Authors:  Linda C Cummings; Gregory S Cooper
Journal:  Cancer Detect Prev       Date:  2008-04-10

6.  Comprehensive spectral endoscopy of topically applied SERS nanoparticles in the rat esophagus.

Authors:  Yu W Wang; Altaz Khan; Steven Y Leigh; Danni Wang; Ye Chen; Daphne Meza; Jonathan T C Liu
Journal:  Biomed Opt Express       Date:  2014-08-01       Impact factor: 3.732

7.  Significance of 18F-Fluorodeoxyglucose Uptake at the Gastroesophageal Junction: Comparison of PET to Esophagogastroduodenoscopy.

Authors:  Joshua Stagg; Irfan Farukhi; Francisco Lazaga; Chiarra Thompson; Ledjona Bradshaw; Mohamed Kaif; Aron Gould-Simon; Robert Schmidt
Journal:  Dig Dis Sci       Date:  2014-12-14       Impact factor: 3.199

Review 8.  Chemoprevention of esophageal squamous cell carcinoma.

Authors:  Gary D Stoner; Li-Shu Wang; Tong Chen
Journal:  Toxicol Appl Pharmacol       Date:  2007-03-15       Impact factor: 4.219

9.  Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study.

Authors:  Sarah J Crane; G Richard Locke; William S Harmsen; Alan R Zinsmeister; Yvonne Romero; Nicholas J Talley
Journal:  Mayo Clin Proc       Date:  2008-10       Impact factor: 7.616

10.  Capecitabine treatment patterns in patients with gastroesophageal cancer in the United States.

Authors:  Muhammad Wasif Saif; Nianwen Shi; Susan Zelt
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.